Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6810135 | 7357509 | F | 6810135-1 | 20100331 | 20100617 | 20100630 | EXP | CH-GENZYME-POMP-1000908 | GENZYMEP | 27 | YR | F | Y | 42 | KG | 20100630 | MD | SWITZERLAND |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
6810135 | 1014006329 | PS | MYOZYME | 1 | INTRAVENOUS | 20 MG/KG, Q2W | |||||
6810135 | 1014006330 | C | PANTOZOL | 2 | 20 MG, UNK | ||||||
6810135 | 1014006331 | C | CLEMASTINE FUMARATE | 1 | 1 MG, UNK |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
6810135 | 1014006329 | GLYCOGEN STORAGE DISEASE TYPE II |
6810135 | 1014006330 | PREMEDICATION |
6810135 | 1014006331 | PREMEDICATION |
Outcome of event
Event ID | OUTC COD |
---|---|
6810135 | HO |
6810135 | OT |
Reactions reported
Event ID | PT |
---|---|
6810135 | CHILLS |
6810135 | DYSPEPSIA |
6810135 | GLOMERULONEPHRITIS MEMBRANOUS |
6810135 | NEPHROTIC SYNDROME |
6810135 | RASH |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
6810135 | 1014006329 | 20070612 |